These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1058 related articles for article (PubMed ID: 16293162)
1. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. Appel SJ; Harrell JS; Davenport ML J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162 [TBL] [Abstract][Full Text] [Related]
2. Measures of obesity and metabolic syndrome in Indian Americans in northern California. Misra KB; Endemann SW; Ayer M Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232 [TBL] [Abstract][Full Text] [Related]
3. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Santos AC; Lopes C; Guimarães JT; Barros H Int J Obes (Lond); 2005 Dec; 29(12):1452-6. PubMed ID: 16077717 [TBL] [Abstract][Full Text] [Related]
4. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome. de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure. Egan BM; Papademetriou V; Wofford M; Calhoun D; Fernandes J; Riehle JE; Nesbitt S; Michelson E; Julius S; Am J Hypertens; 2005 Jan; 18(1):3-12. PubMed ID: 15691610 [TBL] [Abstract][Full Text] [Related]
7. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents. Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902 [TBL] [Abstract][Full Text] [Related]
8. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
10. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome. Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253 [TBL] [Abstract][Full Text] [Related]
11. The importance of diagnostic criteria in the association between the metabolic syndrome and cardiovascular disease in obese subjects. Vidal J; Morínigo R; Codoceo VH; Casamitjana R; Pellitero S; Gomis R Int J Obes (Lond); 2005 Jun; 29(6):668-74. PubMed ID: 15753955 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560 [TBL] [Abstract][Full Text] [Related]
13. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141 [TBL] [Abstract][Full Text] [Related]
14. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054 [TBL] [Abstract][Full Text] [Related]
15. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Cheung BM; Wat NM; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS Clin Endocrinol (Oxf); 2008 May; 68(5):730-7. PubMed ID: 17980012 [TBL] [Abstract][Full Text] [Related]
16. Maternal waist circumference and the prediction of children's metabolic syndrome. Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567 [TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Sebestjen M; Zegura B; Guzic-Salobir B; Keber I Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736 [TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Hung J; McQuillan BM; Thompson PL; Beilby JP Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction. Amowitz LL; Ridker PM; Rifai N; Loughrey CM; Komaroff AL J Womens Health (Larchmt); 2004 Mar; 13(2):165-75; discussion 175. PubMed ID: 15072730 [TBL] [Abstract][Full Text] [Related]
20. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]